Top Diabetes Learnings of 2016: A Critical Update

Learning Objectives

To understand the role of diabetes on CV outcomes
To appreciate the role of choosing wisely in diabetes with respect to antihyperglycemic therapy
To understand the data on emerging clinical trials in diabetes
To appreciate the difference in management in primary vs. secondary prevention in diabetes

Agenda

Click to See Video in Chapters

00:00:00

Introduction
Dr. Ronald Goldenberg

00:05:47

Diabetes Cardiovascular Outcome Trials: 2016 Update
Dr. Subodh Verma

00:43:50

Type 2 Diabetes and PAD: Frequent Bedfellows
Dr. Mohammed Al-Omran

01:00:34

Case Vignettes in T2D: How to Individualize Pharmacotherapy in 2016?
Dr. Harpreet Bajaj / Dr. Ronald Goldenberg

01:26:33

Initial Combination Therapy For All in Type 2 Diabetes: Is it Ready for Prime Time in 2016?
Dr. Ronald Goldenberg

01:44:17

Diabetes in South Asians: Implications for Treatment
Dr. Subodh Verma

02:07:16

Glucagon in T2D: The Impact of Incretin Agents and SGLT2i
Dr. Ronald Goldenberg

02:24:52

Key Translational Messages for Primary Care Physicians
Dr. Shafiq Qaadri

Chairs

Ronald Goldenberg
MD, FRCPC, FACE
Consultant Endocrinologist, North York General Hospital
LMC Diabetes & Endocrinology

Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor Surgery and Pharmacology & Toxicology, University of Toronto

Faculty

Mohammed Al-Omran
MD, MSc, FRCSC
Head, Division of Vascular Surgery, St. Michael’s Hospital
Professor, Department of Surgery, University of Toronto

Harpreet Singh Bajaj
MD, MPH, ECNU, FACE
Clinical Endocrinologist, LMC Diabetes & Endocrinology, Brampton
Tariff Chairman, Section of Endocrinology, Ontario Medical Association
Founding Chairman, “STOP Diabetes” Foundation Inc.

Shafiq Qaadr
MD, MPP
Family Physician
CME Lecturer
Medical Writer

View Conference Details